Fosinoprilum natricum, Hydrochlorothiazidum

Medicinal product name Monozide 20 mg/12.5 mg tablets
Pharmaceutical form Tablet
Strength 20 mg/12.5 mg 
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.)
KZSL1 Next lowest cost medicine
Package leafletMS Word document 01-03-2022
Summary of product characteristicsMS Word document 01-03-2022
Risk minimisation measuresVēstule veselības aprūpes speciālistam Vēstule veselības aprūpes speciālistam
ATC code C09BA09 Agents acting on the renin-angiotensin system

Medicinal products (2)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N28
(20 mg/12,5 mg)
PVC/PVDC/Al blister 7.53 
KZSL1*
03-0033-01 Labelling text Labelling text Aug 9, 2018
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N30
(20 mg/12,5 mg)
PVC/PVDC/Al blister    03-0033-02 Labelling text Labelling text Aug 9, 2018
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. 03-0033
MA suspended from the medicinal product register by request of PharmaSwiss Ceska republika s.r.o., Czech Republic Dec 22, 2023
Permitted to distribute until Jun 22, 2024
Marketing authorisation holder, country PharmaSwiss Ceska republika s.r.o., Czech Republic